Home › Free Stock Grades › NEO
NeoGenomics, Inc. (NEO) Stock Grade
NEO · Healthcare
C
Market Cap
$495.7M
P/E Ratio
—
Revenue Growth (YoY)
+10.1%
Net Margin
-14.9%
Return on Equity
—
Dividend Yield
None
About NeoGenomics, Inc.'s fundamentals
NeoGenomics is a medical diagnostics company with a market capitalization of $495.7 million that achieved 10.1% year-over-year revenue growth. However, the company is currently unprofitable, operating at a net margin of -14.9% and reporting a net loss in its latest annual statement. The company does not pay a dividend, suggesting management is reinvesting resources into operations rather than returning capital to shareholders.